Matthew Rees

35PUBLICATIONS
503CO-AUTHORS
Molecular targetsCentral nervous systemPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Characterisation of biological macromolecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (35)

|Jul 14, 2026
CDK8 Inhibition Releases the Muscle Differentiation Block in Fusion-driven Alveolar Rhabdomyosarcoma.

|May 22, 2026
Genetic Drivers of Sensitivity or Resistance to RAS(ON) Multiselective Inhibitors in NRAS-Mutated Melanoma.

|May 06, 2026
Expanding the human proteome with microproteins and peptideins.

|Oct 27, 2025
PI3Kα Inhibitor and Degrader Inavolisib Can Co-opt FGFR2 to Enhance Responses in Patients with PIK3CA-Mutated Solid Tumors and in Preclinical Models.

Dejan Juric, Kyung Song, Radia M Johnson

|Oct 03, 2025
Targeting histone H2B acetylated enhanceosomes via p300/CBP degradation in prostate cancer.

Jie Luo, Zhixiang Chen, Yuanyuan Qiao

|Sep 13, 2025
CF10 Displayed Improved Activity Relative to 5-FU in a Mouse CRLM Model Under Conditions of Physiological Folate.

Charles Chidi Okechukwu, Xue Ma, Wencheng Li

Pageof 6

Frequent Collaborators

27 joint publications

Jennifer Roth

21 joint publications

Melissa Ronan

7 joint publications

Andrew S Boghossian

4 joint publications

Julien Dilly